Prospective evaluation of the gut microbiome and response to neoadjuvant therapy (NAT) in early-stage triple negative breast cancer (TNBC)

被引：0
|
作者：
Abuhadra, Nour [1 ]
Chang, Chia-Chi [1 ]
Yam, Clinton [1 ]
Sun, Ryan [1 ]
Huo, Lei [1 ]
White, Jason [1 ]
Ravenberg, Elizabeth E. [1 ]
Litton, Jennifer [1 ]
Lim, Bora [1 ]
Ueno, Naoto T. [1 ]
Arun, Banu [1 ]
Tripathy, Debu [1 ]
Damodaran, Senthil [1 ]
Murthy, Rashmi [1 ]
Valero, Vicente [1 ]
Hortobagyi, Gabriel [1 ]
Ibrahim, Nuhad [1 ]
Thompson, Alastair [2 ]
Mittendorf, Elizabeth [3 ]
Moulder, Stacy [1 ]
Jenq, Robert [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS4-05
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The impact of gut microbial composition on response to neoadjuvant chemotherapy (NACT) in early-stage triple negative breast cancer (TNBC).
    Abuhadra, Nour
    Chang, Chia-Chi
    Yam, Clinton
    White, Jason B.
    Ravenberg, Elizabeth
    Lim, Bora
    Ueno, Naoto T.
    Litton, Jennifer Keating
    Arun, Banu
    Damodaran, Senthil
    Murthy, Rashmi Krishna
    Ibrahim, Nuhad K.
    Hortobagyi, Gabriel N.
    Valero, Vicente
    Tripathy, Debu
    Thompson, Alastair Mark
    Mittendorf, Elizabeth A.
    Huo, Lei
    Moulder, Stacy L.
    Jenq, Robert R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] Prospective evaluation of patients with metaplastic (Mp) triple negative breast cancer (TNBC): Molecular characteristics and outcomes with neoadjuvant therapy (NAT)
    Abuhadra, Nour
    Yam, Clinton
    Sun, Ryan
    Huo, Lei
    White, Jason
    Ravenberg, Elizabeth
    Adrada, Beatriz
    Sahin, Aysegul
    Litton, Jennifer
    Lim, Bora
    Ueno, Naoto T.
    Arun, Banu
    Tripathy, Debu
    Damodaran, Senthil
    Murthy, Rashmi
    Valero, Vicente
    Hortobagyi, Gabriel
    Ibrahim, Nuhad
    Thompson, Alastair
    Lucci, Anthony
    Mittendorf, Elizabeth
    Moulder, Stacy
    Chang, Jeffrey
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [3] Mechanisms of resistance of chemotherapy in early-stage triple negative breast cancer (TNBC)
    Wein, Lironne
    Loi, Sherene
    [J]. BREAST, 2017, 34 : S27 - S30
  • [4] Early prediction of response to Neoadjuvant Immunotherapy in Triple Negative Breast Cancer (TNBC) with DCEMRI
    Rauch, Gaiane
    Guirguis, Mary
    Patel, Miral
    Candelaria, Rosalind
    Mohamed, Rania
    Moseley, Tanya
    Le-Petross, H. T. Carisa
    Leung, Jessica
    Whitman, Gary
    Lane, Deanna
    Scoggins, Marion
    Perez, Frances
    Sun, Jia
    Pashapoor, Sanaz
    Xu, Zhan
    White, Jason
    Wei, Peng
    Reed, Brandy
    Son, Jong Bum
    Hwang, Ken-Pin
    Panthi, Bikash
    Korkut, Anil
    Huo, Lei
    Hunt, Kelly
    Clayborn, Alyson
    Litton, Jennifer
    Valero, Vicente
    Tripathy, Debu
    Yam, Clinton
    Yang, Wei
    Ma, Jingfei
    Adrada, Beatriz
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [5] Prospective evaluation of the breast microbiome and tumor microenvironment-related biomarkers of response to neoadjuvant systemic therapy in triple negative breast cancer
    Hennessy, Maeve
    Morais, Emilene S.
    Devoy, Ciaran
    Walsh, Grace
    Crowley, Erin
    Lynch, Emer
    Twomey, Maria
    Girleanu, Corina
    Dahly, Darren L.
    O'Driscoll, Lorraine
    Foley, Cathriona
    Bennett, Michael William
    O'Hanlon, Deirdre
    Tangney, Mark
    Connolly, Roisin M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Characterization of Gut Microbiome of patients with early-stage breast cancer treated with neoadjuvant chemotherapy
    Thommen, Ludmila
    Heidrich, Vitor
    de Andrade, Rosangela Vieira
    Weis, Luiza Nardin
    Felipe, Maria Sueli Soares
    Vita, Melissa Lole Da Cas
    Pinto, Thiago David Alves
    Camargo, Anamaria
    Barroso-Sousa, Romualdo
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [7] Optimization of Neoadjuvant Therapy for Early-Stage Triple-Negative and HER2+Breast Cancer
    Phadke, Sneha
    [J]. CURRENT ONCOLOGY REPORTS, 2022, 24 (12) : 1779 - 1789
  • [8] Optimization of Neoadjuvant Therapy for Early-Stage Triple-Negative and HER2 + Breast Cancer
    Sneha Phadke
    [J]. Current Oncology Reports, 2022, 24 : 1779 - 1789
  • [9] Neoadjuvant therapy in early-stage breast cancer
    Moreno-Aspitia, Alvaro
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 82 (02) : 187 - 199
  • [10] Immune phenotype and response to neoadjuvant systemic therapy (NAST) in triple negative breast cancer (TNBC).
    Yam, Clinton
    Alatrash, Gheath
    Yen, Er-Yen
    Garber, Haven
    Philips, Anne V.
    Huo, Lei
    Yang, Fei
    Bassett, Roland L.
    Sun, Xiangjie
    Cuentas, Edwin Roger Parra
    Symmans, William Fraser
    Seth, Sahil
    White, Jason B.
    Rauch, Gaiane M.
    Damodaran, Senthil
    Litton, Jennifer Keating
    Wargo, Jennifer Ann
    Hortobagyi, Gabriel N.
    Moulder, Stacy L.
    Mittendor, Elizabeth A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345